Modern technology: in our Center for Oncological Diagnostics and Radiotherapy at the ISAR Clinic, our Department of Nuclear Medicine has a SPECT-capable gamma camera for conventional imaging and a PET/CT of the latest generation.

Nuclear medicine describes the use of weakly radioactively labeled substances in the context of molecular imaging and therapy in medicine.

In oncology, the use of so-called radiopharmaceuticals or radiotracers provides functional information on tumor diseases that goes beyond radiological or morphological imaging. Nuclear medicine can therefore contribute to the optimization of therapy for certain oncological issues.

In addition, radiopharmaceuticals can also be used to treat various types of tumors directly.

Conventional imaging

Conventional imaging using scintigraphy and SPECT is used for various tumor diseases.

One of the most common examinations is bone scintigraphy. Using weakly radioactively labeled phosphate compounds, bone metastases can be detected at an early stage or differentiated from other benign changes (e.g. inflammation, osteoarthritis, bone fracture) and ruled out. In addition, scintigraphy and SPECT can also be used for other tumor diseases (e.g. assessment of kidney function and excretion in kidney tumors, clarification of abnormal nodules in the kidneys, etc.).